Karin Jooss

Companies

• Fate TherapeuticsBoard member Mar 18, 2019 to now¹
• Gritstone bio, Inc.Officer Sep 27, 2018 to May 17, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• FTFate Therapeutics FATE9,848 shares³$18.5K at $1.88Jun 9, 2022
• GBGritstone bio, Inc.683,526 shares⁴May 16, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• May 16, 2024Sold 13,749 shares at $0.75 of Gritstone bio, Inc.⁴
• May 15, 2024Granted 27,128 shares of Gritstone bio, Inc.⁴
• Feb 1, 2024Granted 40,000 shares of Gritstone bio, Inc.⁵
• Feb 2, 2023Granted 252,763 shares of Gritstone bio, Inc.⁶
• Jun 9, 2022Granted 8,650 shares of Fate Therapeutics³
• Jun 3, 2022Sold 1,483 shares at $22.82 of Fate Therapeutics⁷
• Jan 31, 2022Granted 27,600 shares of Gritstone bio, Inc.⁸
• Jan 7, 2021Granted 27,900 shares of Gritstone bio, Inc.⁹